Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
Level 12 Salary Range $30.00-53.67/hour Type of Position Staff Position Time Status Full-Time Required Education BS Click here for more information about equivalencies: https://hr.uky.edu/employment
-
variety of technical procedures including HLA typing by rSSO and next generation sequencing methods, Luminex based HLA Antibody identification, and donor/recipient flow cytometric cross-matching
-
for independently performing and validating complex immunohematology procedures—including blood typing, antibody screening and identification, compatibility testing, and investigation of transfusion reactions
-
University of California, San Francisco | San Francisco, California | United States | about 10 hours ago
Surgery Per Diem 87384BR Job Summary This is a training position. The Trainee will be enrolled in a state-approved training program for the Clinical Histocompatibility Scientist (CHS). (https
-
lack of specificity and relatively short half-life. Application of new technology to the production of monoclonal antibodies to the GIP receptor which antagonise GIP action overcomes these difficulties
-
Duke Center for Human Systems Immunology is seeking a detail-oriented scientist to fulfill a key role as a Lab Research Analyst I. This individual will develop and perform assays to evaluate antibody
-
techniques. • Extraction of nucleic acids, conventional and quantitative PCR; nucleic acid electrophoresis. • Advanced handling of confocal microscope • Cell-labeling techniques with antibodies, ELISA
-
for follow-up antibody design. Offering the right context and finding ways for experts to translate their domain knowledge into flexible and mineable formats for the recommender approach will be crucial
-
Screening Core within the Department of Host Microbe Interactions at St. Jude seeks a skilled and highly motivated candidate with experience in Antibody Discovery . This is a unique opportunity to join as an
-
on mechanisms regulating the activation of cells of the immune system, cancer immunotherapy with the use of monoclonal antibodies, and effector cells including cells modified with chimeric antigen receptors (CAR